ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

ARDT vs SGRY // OPERATING MARGIN

Ardent Health Inc. (NYSE) VS. Surgery Partners Inc. (NASDAQ) • 15-METRIC TALLY: ARDT 3 — SGRY 4
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARDT VS. SGRY) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC ARDT SGRY SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 10.50% 9.90% +0.60 ARDT /roic <GO>
EV/EBITDA & P/E Valuation — 9.7x — TIE /valuation <GO>
Free Cash Flow Yield — 6.44% — TIE /fcf-yield <GO>
Operating Margin ACTIVE — 45.80% — TIE /operating-margins <GO>
Net Profit Margin 2.10% -9.20% +11.30 ARDT /net-margins <GO>
Revenue Growth (YoY) 6.00% 6.60% -0.60 SGRY /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.67 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 8/9 -1.00 SGRY /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 61.4 86.2 -24.80 SGRY /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — 0.99 — TIE /macro-sensitivity <GO>
Forward P/E Multiple 11.9x 22.0x -10.10 ARDT /forward-pe <GO>
Enterprise Scale & Market Cap $1.73B $3.04B -$1.30B SGRY /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR ARDT REV SGRY REV ARDT GROSS % SGRY GROSS % ARDT FCF SGRY FCF
FY 2025 $6.32B $0 — — $470.5M $195.6M
FY 2024 $5.97B $0 — — $315.0M $209.7M
FY 2023 $5.41B $0 — — $221.7M $293.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARDT // BETA —
SGRY // BETA 0.99